Nitric oxide and MCP-1 regulation in LPS activated rat Kupffer cells

George Kolios1, Vassilis Valatas, Pinelopi Manousou

  • 1Department of Gastroenterology, University of Crete, Greece. gkolios@med.uoc.gr

Insights

Kupffer cells produce nitric oxide (NO) and Monocyte Chemoattractant Protein-1 (MCP-1) in liver disorders. These molecules are likely independent immunoregulatory pathways, not co-regulated, suggesting distinct roles in hepatic disease.

Area of Science:

  • Immunology
  • Hepatology
  • Cell Biology

Background:

  • Macrophages, specifically Kupffer cells (KC) in the liver, are key producers of soluble mediators.
  • Previous studies indicated co-regulation of nitric oxide (NO) and Monocyte Chemoattractant Protein-1 (MCP-1) in activated macrophages.
  • Understanding KC mediator production is crucial for liver disorder pathogenesis.

Purpose of the Study:

  • To investigate the in vitro co-regulation of NO and MCP-1 production in activated rat Kupffer cells.
  • To determine the role of PI3-kinase and NO synthase pathways in KC mediator release.
  • To elucidate the relationship between NO and MCP-1 production by KC in response to lipopolysaccharide (LPS).

Main Methods:

  • Primary rat Kupffer cells were cultured and stimulated with LPS.
  • Cells were pre-treated with inhibitors of NO synthesis (L-NAME) and PI3-kinase (Wortmannin), or with MCP-1.
  • NO and MCP-1 levels in culture supernatants were quantified using Griess reaction and ELISA, respectively.

Main Results:

  • LPS significantly increased both NO and MCP-1 secretion from Kupffer cells.
  • L-NAME inhibited NO production but did not affect MCP-1 levels.
  • Wortmannin inhibited both NO and MCP-1 production, indicating PI3-kinase involvement.
  • A positive correlation was observed between NO and MCP-1 with LPS and Wortmannin, but not L-NAME.
  • Exogenous MCP-1 did not enhance NO production.

Conclusions:

  • Kupffer cells are a significant source of NO and MCP-1 in liver disorders.
  • NO and MCP-1 production by KC are likely regulated by independent pathways, possibly involving PI3-kinase.
  • These findings suggest distinct immunoregulatory roles for NO and MCP-1 in hepatic disease pathogenesis.